Eli Lilly and Company

Eli Lilly is a US-based pharmaceutical company with its headquarters in Indianapolis, Indiana. The company is known for its brands, including Mounjaro, Zepbound, and insulin products. It is focusing on the research, development, and commercialization of differentiated therapies to address diabetes, obesity, cancer, immunology, and neuroscience. The pharmaceutical company is led by the Chair and CEO David A. Ricks.

The pharmaceutical company's most significant environmental achievement is its high percentage of water recycling and water risk management at the site level. For example, in 2024, Lilly's facilities are estimated to have recycled or reused 290 billion liters of water, accounting for 97.5% of the water used.

Lilly has completed water management plans at all its manufacturing sites located in water-stressed regions. The company set the expectations for its sustainable water management based on the Alliance for Water Stewardship International Water Stewardship Standard. The water management plans address governance, water balance, water quality, water-related ecosystems and areas of high water use, and safe water and sanitation.

Furthermore, Lilly has made incredible progress towards reducing the impact of Pharmaceuticals in the Environment (PIE). Indeed, all Lilly's manufacturing facilities met predicted no-effect concentration (PNEC) values for pharmaceuticals in the environment in 2024. Each of the company's manufacturing site's wastewaters emitted less than 10% of the PNEC-based limits for individual pharmaceutical compounds. All of Lilly's contract manufacturing organizations were audited to ensure that their processes and systems were appropriately controlled to meet the PNEC-based limits.